Communication
Organic & Biomolecular Chemistry
In conclusion, we have developed the first catalytic enantio-
selective amide allylation of acyclic α-ketoesters, which
achieved excellent reaction performance while exemplifying
the wide substrate and reagent generality to provide ready
access to a variety of the ester functionalised enantiopure
α-methylene-γ-butyrolactones. Future studies will explore the
full synthetic potential of these reaction systems and drive
expansion of the amide allylation method to be of more
general utility.
Scheme 2 Transformations for absolute configuration determinations.
Acknowledgements
This work was supported in part by a Grant-in-Aid for Scienti-
fic Research from the Ministry of Education, Culture, Sports,
Science and Technology, Japan.
ethane (DCE) at 50 °C,4,5 and could be used to furnish the
common lactones, denoted as 4a, without noticeable degra-
dation of the stereochemical qualities for all cases (Table 1,
entries 1–8). The comparative analysis of the HPLC results
showed remarkable consistency of the stereochemical prefer-
ences, providing clear evidence that all the homoallylic precur-
sors analysed here include the S absolute configurations
resulting mechanistically from Re-face additions of 2 onto the
prochiral carbonyl centres of 1.5
Notes and references
1 Y. Yamamoto and N. Asao, Chem. Rev., 1993, 93, 2207–
2293.
2 (a) K. Tanaka, H. Yoda, Y. Isobe and A. Kaji, J. Org. Chem.,
1986, 51, 1856–1866; (b) K. Tanaka, H. Yoda, Y. Isobe and
A. Kaji, Tetrahedron Lett., 1985, 26, 1337–1340.
In a similar manner, 3i–k were shown to undergo the PTSA-
promoted lactonisation to afford 4b–d in satisfactorily high
isolated yields, while still maintaining the excellent enantio-
purities (Table 1, entries 9–11). Based on the above results,
stereochemical assignments of 3i and 3j were also achieved by
replacing their ester functionalities with the methyl one for
comparison with the authentic standard of (S)-3c (Scheme 2a).
After the transformation through hydrolysis with LiOH and
subsequent esterification with MeI to obtain the corres-
ponding methyl esters 3c, the absolute configurations of these
compounds, together with those of the respective lactones,
were established by the chiral HPLC analyses to be of the same
S-chirality, giving a clear indication of the same preferences
for the Re-face attacks involved in the amide allylations of 1b
and 1c. On the other hand, the absolute stereochemistry of 3k,
which remained unclear, could be assigned on the basis of
comparison with the reported optical rotation.12 In this case,
this material was needed to be transformed to 4d′, an ethyl
ester analogue of 4d, via simultaneous ester exchange/lactoni-
sation upon treatment with ethanolic PTSA at 60 °C, thereby
obtaining the desired product (Scheme 2b). By comparison of
its optical rotation with the literature data, the absolute stereo-
chemistry of 4d′ was assigned to be R, reflecting the fact that
3k and 4d share the same configurations, again indicative of
the involvement of the same stereochemistry determining
step. Finally, it is indeed important to note that the overall
assessment of the stereochemical outcomes shows complete
uniformity of the Re-face selectivity, which is in accordance
with our mechanistic picture of how the previous catalytic
system functioned,5 leading to a clear perspective on the
origins of the excellent levels of asymmetric induction
observed for the current catalytic system.13
3 (a) T. Suzuki, J. Atsumi, T. Sengoku, M. Takahashi and
H. Yoda, J. Organomet. Chem., 2010, 695, 128–136;
(b) T. Suzuki, T. Sengoku, M. Takahashi and H. Yoda, Tetra-
hedron Lett., 2008, 49, 4701–4703.
4 Y. Murata, M. Takahashi, F. Yagishita, M. Sakamoto,
T. Sengoku and H. Yoda, Org. Lett., 2013, 15, 6182–6185.
5 M. Takahashi, Y. Murata, F. Yagishita, M. Sakamoto,
T. Sengoku and H. Yoda, Chem. – Eur. J., 2014, 20, 11091–
11100.
6 (a) R. A. Kitson, A. Millemaggi and R. J. K. Taylor, Angew.
Chem., Int. Ed., 2009, 48, 9426–9451; (b) J.-P. Leopoittevin,
V. Berl and E. Giménez-Arnau, Chem. Rec., 2009, 9,
258–270; (c) A. Bachelier, R. Mayer and C. D. Klein, Bioorg.
Med. Chem. Lett., 2006, 16, 5605–5609; (d) B. Siedle,
A. J. García-Piñeres, R. Murillo, J. Schulte-Mönting,
V. Castro, P. Rüngeler, C. A. Klaas, F. B. Da Costa, W. Kisiel
and I. Merfort, J. Med. Chem., 2004, 47, 6042–6054;
(e) P. Rüngeler, V. Castro, G. Mora, N. Gören,
W. Vichnewski, H. L. Pahl, I. Merfort and T. J. Schmidt,
Bioorg. Med. Chem., 1999, 7, 2343–2352; (f) M. Takahashi,
T. Sudo, Y. Murata, T. Sengoku and H. Yoda, Nat. Prod.
Commun., 2013, 8, 889–896; (g) M. Takahashi, J. Atsumi,
T. Sengoku and H. Yoda, Synthesis, 2010, 3282–3288.
7 (a) R. Infante, J. Nieto and C. Andres, Chem. – Eur. J., 2012,
18, 4375–4379; (b) K. Zheng, B. Qin, X. Liu and X. Feng,
J. Org. Chem., 2007, 72, 8478–8483; (c) L. C. Wieland,
H. Deng, M. L. Snapper and A. H. Hoveyda, J. Am. Chem.
Soc., 2005, 127, 15453–15456; (d) G. Blay, I. Fernández,
A. Marco-Aleixandre and J. R. Pedro, Org. Lett., 2006, 8,
1287–1290; (e) K. Funabashi, M. Jachmann, M. Kanai and
M. Shibasaki, Angew. Chem., Int. Ed., 2003, 42, 5489–5492;
7688 | Org. Biomol. Chem., 2014, 12, 7686–7689
This journal is © The Royal Society of Chemistry 2014